Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the USA.

Cheng, Mindy M; Reyes, Carolina; Satram, Sacha; Birch, Helen; Gibbons, Daniel C; Drysdale, Myriam; Bell, Christopher F; Suyundikov, Anvar; Ding, Xiao; Maher, M Cyrus; Yeh, Wendy; Telenti, Amalio; Corey, Lawrence

Cheng, Mindy M; Reyes, Carolina; Satram, Sacha; Birch, Helen; Gibbons, Daniel C; Drysdale, Myriam; Bell, Christopher F; Suyundikov, Anvar; Ding, Xiao; Maher, M Cyrus; Yeh, Wendy; Telenti, Amalio; Corey, Lawrence.

Afiliação

Cheng MM; Vir Biotechnology, 499 Illinois St., Suite 500, San Francisco, CA, 94158, USA. mcheng@vir.bio.
Reyes C; Vir Biotechnology, San Francisco, CA, 94158, USA.
Satram S; Vir Biotechnology, San Francisco, CA, 94158, USA.
Birch H; GSK, Brentford, Middlesex, UK.
Gibbons DC; GSK, Brentford, Middlesex, UK.
Drysdale M; GSK, Brentford, Middlesex, UK.
Bell CF; GSK, Durham, NC, USA.
Suyundikov A; Vir Biotechnology, San Francisco, CA, 94158, USA.
Ding X; Vir Biotechnology, San Francisco, CA, 94158, USA.
Maher MC; Vir Biotechnology, San Francisco, CA, 94158, USA.
Yeh W; Vir Biotechnology, San Francisco, CA, 94158, USA.
Telenti A; Vir Biotechnology, San Francisco, CA, 94158, USA.
Corey L; Fred Hutchinson Cancer Research Center Vaccine and Infectious Diseases Division, Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.

Infect Dis Ther ; 12(2): 607-621, 2023 Feb.

Article em En | MEDLINE | ID: mdl-36629998

Palavras-chave

COVID-19; Effectiveness; Monoclonal antibody; Real-world; SARS-CoV-2; Sotrovimab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Infect Dis Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google